TASK-1 Channels: Functional Role in Arterial Smooth Muscle Cells

被引:0
作者
Shvetsova A.A. [1 ]
Gaynullina D.K. [1 ]
Tarasova O.S. [1 ]
机构
[1] Department of Biology, Moscow State University, Moscow
基金
俄罗斯科学基金会;
关键词
anticontractile influence; arterial smooth muscle cells; membrane potential; potassium channels; TASK-1; channels; vascular tone;
D O I
10.3103/S0096392522020109
中图分类号
学科分类号
摘要
Abstract: The change in the diameter of small arteries and arterioles is a key mechanism for regulating the resistance of the vascular bed and blood pressure and blood flow in organs and tissues. The tone of arterial smooth muscle cells (SMC) depends on the level of membrane potential (MP), which, in turn, is determined by the balance of depolarizing and hyperpolarizing currents. The main hyperpolarizing current of SMC is the outward potassium current. Activation and opening of potassium channels counteract depolarization and inhibit calcium entry into the cell and contraction. Thus, potassium channels play an anticonstrictor role in the arteries. TASK-1 channels, members of the two-pore domain potassium channel family (K2P), have relatively recently been described in the vasculature. It is known that TASK-1 channels mediate outward potassium leakage current in arterial SMC. In addition, TASK-1 channels are regulated by a number of stimuli: their activity augments with an increase of extracellular pH, decreases in hypoxia, and can also change under the influence of inhalation/local anesthetics and vasoactive substances. TASK-1 channels play an important role in the regulation of arterial tone in pulmonary circulation; their dysfunction is one of the causes of arterial pulmonary hypertension development. In systemic arteries of adult animals, the influence of TASK-1 channels under normal pH is small or absent, but it can manifest itself under conditions of extracellular alkalosis. In addition, the anticontractile role of TASK-1 channels is more pronounced at the early stages of postnatal development. This review outlines the current understanding of the functional role and regulation of TASK-1 channels in the vascular system. © 2022, Allerton Press, Inc.
引用
收藏
页码:64 / 75
页数:11
相关论文
共 80 条
  • [1] Tykocki N.R., Boerman E.M., Jackson W.F., Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles, Comp. Physiol, 7, pp. 485-581, (2017)
  • [2] Gurney A., Manoury B., Two-pore potassium channels in the cardiovascular system, Eur. Biophys. J., 38, pp. 305-318, (2009)
  • [3] Shvetsova A.A., Gaynullina D.K., Schmidt N., Bugert P., Lukoshkova E.V., Tarasova O.S., Schubert R., TASK-1 channel blockade by AVE1231 increases vasocontractile responses and BP in 1- to 2‑week-old but not adult rats, Br. J. Pharmacol, 177, pp. 5148-5162, (2020)
  • [4] Lloyd E.E., Marrelli S.P., Bryan R.M., cGMP does not activate two-pore domain K<sup>+</sup> channels in cerebrovascular smooth muscle, Am. J. Physiol.: Heart Circ. Physiol, 296, pp. 1774-1780, (2009)
  • [5] Antigny F., Hautefort A., Meloche J., Potassium channel subfamily K member 3 (KCNK3) contributes to the development of pulmonary arterial hypertension, Circulation, 133, pp. 1371-1385, (2016)
  • [6] Gardener M.J., Johnson I.T., Burnham M.P., Edward G., Heagerty A.M., Weston A.H., Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries, Br. J. Pharmacol, 142, pp. 192-202, (2004)
  • [7] Ma L., Roman-Campos D., Austin E.D., A novel channelopathy in pulmonary arterial hypertension, N. Engl. J. Med, 369, pp. 351-361, (2013)
  • [8] Navas T., P., Tenorio Castaño, J., Palomino Doza, J., Arias Lajara, P., Gordo Trujillo, G., López Mese-guer, M., Román Broto, A., Lapunzina Abadía, P., and Escribano Subía, P., An homozygous mutation in KCNK3 is associated with an aggressive form of hereditary pulmonary arterial hypertension, Clin. Genet, 91, pp. 453-457, (2017)
  • [9] Zhang H.S., Liu Q., Piao C.M., Zhu Y., Li Q.Q., Du J., Gu H., Genotypes and phenotypes of Chinese pediatric patients with idiopathic and heritable pulmonary arterial hypertension – a single-center study, Can. J. Cardiol, 35, pp. 1851-1856, (2019)
  • [10] Haarman M.G., Kerstjens-Frederikse W.S., Vissia-Kazemier T.R., Breeman K.T.N., Timens W., Vos Y.J., Roofthooft M.T.R., Hillege H.L., Berger R.M.F., The genetic epidemiology of pediatric pulmonary arterial hypertension, J. Pediatr, 225, pp. 65-73, (2020)